Pharmadrug Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 0.002531 million compared to CAD 0.00408 million a year ago. Net loss was CAD 0.852334 million compared to CAD 1.32 million a year ago. Basic loss per share from continuing operations was CAD 0.009 compared to CAD 0.003 a year ago.
For the nine months, sales was CAD 0.003395 million compared to CAD 0.005335 million a year ago. Net loss was CAD 8.29 million compared to CAD 4.21 million a year ago. Basic loss per share from continuing operations was CAD 0.016 compared to CAD 0.009 a year ago.